COMPASS Pathways PLC

COMPASS Pathways Is Accelerating Patient Access To Evidence-Based Innovation In Mental Health Care

AMA Issues Details On First Psychedelics Therapy CPT Code – Thanks To These Psychedelic-Focused Mental Healthcare Companies

Magic Mushrooms to Treat Anorexia? All About Compass' Novel Phase 2 Trial Of Psychedelic's Main Compound

AMA Issues Details On First Psychedelics Therapy CPT Code – Thanks To These Psychedelic-Focused Mental Healthcare Companies

Magic Mushrooms to Treat Anorexia? All About Compass' Novel Phase 2 Trial Of Psychedelic's Main Compound

Compass Pathways Reports Q1 Financial Results, With Increased R&D Expenses Compared To 2021

New Study To Evaluate Magic Mushroom's Therapeutic Potential On Autistic Adults

Compass Pathways Reports Q1 Financial Results, With Increased R&D Expenses Compared To 2021

New Study To Evaluate Magic Mushroom's Therapeutic Potential On Autistic Adults

UK: COMPASS Pathways Forms Partnership To Launch Centre For Mental Health Research And Innovation

Worthy Or Superfluous? Psychedelics Experts Discuss The Sector's Ongoing Patent Debate

COMPASS Pathways PLC Recent News

Psychedelics Advocate, Investor Zappy Says 2021 Is 'The Year To Invest In Plant Medicine'

Get into psychedelics now. That's according to Michael "Zappy" Zapolin, a former Bear Stearns VP turned psychedelics advocate and filmmaker. Zappy's call to invest comes as psychedelics make a continued push towards credibility on the medical, legal and business stages.